The Export Processing Zone Authority (EPZA) has made great strides since it was launched in 1990 as a response to a decline in industrial investment and output, poor export performance and inadequate job and wealth creation.
Since then, the number of investors has grown, the latest being square pharmaceuticals and Be Brawn, a company of great repute in healthcare worldwide. All companies operating at EPZA currently employ over 54,000 people.